Study: NCT05040841

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M3/EAM: Immediate outreach to subject after EAM-identified missed doses
Description: The subject will be contacted if he/she misses ≥4 doses or any three consecutive doses in a 14-day period, reviewed weekly, as identified by the EAM (electronic adherence monitor). There are 52 chances of being identified as nonadherent and linked immediately to existing adherence support in the first 12 months of care with M2.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: S1/Text: Weekly check-in texts
Description: Subject will receive weekly check-in texts in addition to the core adherence support component in the event they are identified as nonadherent and are linked with the Risk of Treatment Failure clinics. Subjects will be sent weekly simple but supportive text messages e.g. how are you? with the offer of a follow-up voice call for 16 consecutive weeks after being identified as nonadherent.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: S1/Text: Weekly check-in texts
Description: Subject will receive weekly check-in texts in addition to the core adherence support component in the event they are identified as nonadherent and are linked with the Risk of Treatment Failure clinics. Subjects will be sent weekly simple but supportive text messages e.g. how are you? with the offer of a follow-up voice call for 16 consecutive weeks after being identified as nonadherent.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: S1/Text: Weekly check-in texts
Description: Subject will receive weekly check-in texts in addition to the core adherence support component in the event they are identified as nonadherent and are linked with the Risk of Treatment Failure clinics. Subjects will be sent weekly simple but supportive text messages e.g. how are you? with the offer of a follow-up voice call for 16 consecutive weeks after being identified as nonadherent.